Business Wire (Thu, 7:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
117 people get CGIX.OB articles and Market Currents by email alert.
Get email alerts on CGIX.OB »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Wed, 8:00AM)
-
Business Wire (Tue, 8:00AM)
-
Business Wire (Mon, 5:38PM)
-
Business Wire (May 15, 2013)
-
Business Wire (May 14, 2013)
-
Business Wire (May 10, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 2, 2013)
-
-
4 IPOs Scheduled For The Week Of March 25thIPOdesktop • Tue, Mar 26 -
-
-
-
IPO Preview: Cancer GeneticsIPOdesktop • Tue, Feb 12
-
5 IPOs Planned For This WeekRenaissance Capital IPO Research • Tue, Feb 12
-
5 IPOs Scheduled For The Week Of February 11IPOdesktop • Mon, Feb 11
-
-
3 IPOs Expected This WeekRenaissance Capital IPO Research • Mon, May 14, 2012
To learn more about Seeking Alpha Pro, click here.
-
-
4 IPOs Scheduled For The Week Of March 25thIPOdesktop • Tue, Mar 26
-
-
-
-
5 IPOs Planned For This WeekRenaissance Capital IPO Research • Tue, Feb 12
-
5 IPOs Scheduled For The Week Of February 11IPOdesktop • Mon, Feb 11
-
3 IPOs Expected This WeekRenaissance Capital IPO Research • Mon, May 14, 2012
-
There are no Transcripts on CGIX.OB.
-
Business Wire (Thu, 7:00AM)
-
Business Wire (Wed, 8:00AM)
-
Business Wire (Tue, 8:00AM)
-
Business Wire (Mon, 5:38PM)
-
Business Wire (May 15, 2013)
-
Business Wire (May 14, 2013)
-
Business Wire (May 10, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 2, 2013)
CGIX.OB vs. ETF Alternatives
Company Description
Currently, there's no company description for CGIX.OB.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, March 11, 2:34 PM Cancer Genetics (CGIX), an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to cancer treatment, lowers its IPO amount to 1.65M shares at an offering price of $10 to $12 per share. The company's previous filing was for 1.85M shares at the same price range. Comment! [Healthcare]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.